Pharmaceuticals - Sainte-Anne-de-Bellevue, Québec, Canada
We are pleased to announce that MTL-PK has now been acquired by Certara, a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Certara is committed to the MTL-PK model of providing high quality, rapid turnaround PK reports for preclinical and early phase clinical studies that our partners have come to expect from us. We are excited about furthering this model with the technology and resources that Certara will provide.
Gmail
Wordpress.com
Google Apps